Allen C. Cheng

ORCID: 0000-0003-3152-116X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Influenza Virus Research Studies
  • Antimicrobial Resistance in Staphylococcus
  • Burkholderia infections and melioidosis
  • Respiratory viral infections research
  • Antibiotic Use and Resistance
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Cardiac Structural Anomalies and Repair
  • COVID-19 Clinical Research Studies
  • Mechanical Circulatory Support Devices
  • SARS-CoV-2 and COVID-19 Research
  • Sepsis Diagnosis and Treatment
  • Infective Endocarditis Diagnosis and Management
  • Vaccine Coverage and Hesitancy
  • Nosocomial Infections in ICU
  • COVID-19 epidemiological studies
  • Streptococcal Infections and Treatments
  • Urinary Tract Infections Management
  • Head and Neck Cancer Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Patient Satisfaction in Healthcare
  • Infection Control in Healthcare
  • Cardiac Valve Diseases and Treatments
  • Antibiotic Resistance in Bacteria
  • Clostridium difficile and Clostridium perfringens research

Alfred Health
2016-2025

Monash University
2016-2025

Monash Health
2023-2025

Legacy Emanuel Medical Center
2014-2024

Legacy Good Samaritan Medical Center
2016-2024

Providence Portland Medical Center
2014-2024

Oregon Medical Research Center
2024

New York Proton Center
2024

Monash Medical Centre
2023-2024

Lindsay Unified School District
2024

The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.We evaluated tocilizumab and sarilumab an ongoing international, multifactorial, adaptive platform trial. Adult Covid-19, within 24 hours after starting organ support the intensive care unit (ICU), were randomly assigned to receive (8 mg per kilogram body weight), (400 mg), or standard (control). primary outcome was respiratory cardiovascular support-free days, on...

10.1056/nejmoa2100433 article EN New England Journal of Medicine 2021-02-25
Ewan C. Goligher Charlotte Bradbury Bryan J. McVerry Patrick R. Lawler Jeffrey S. Berger and 95 more Michelle N. Gong Marc Carrier Harmony R. Reynolds Anand Kumar Alexis F. Turgeon Lucy Z. Kornblith Susan R. Kahn John C. Marshall Keri S. Kim Brett L. Houston Lennie Derde Mary Cushman Tobias Tritschler Derek Angus Lucas C. Godoy Zoe McQuilten Bridget‐Anne Kirwan Michael E. Farkouh Maria M. Brooks Roger Lewis Lindsay R. Berry Elizabeth Lorenzi Anthony Gordon Tania Ahuja Farah Al-Beidh Djillali Annane Yaseen M. Arabi Diptesh Aryal Lisa Baumann Kreuziger Abi Beane Zahra Bhimani Shailesh Bihari Henny H. Billett Lindsay Bond Marc J. M. Bonten Frank Brunkhorst Meredith Buxton Adrian Buzgau Lana A. Castellucci Sweta Chekuri Jen‐Ting Chen Allen C. Cheng Tamta Chkhikvadze Benjamin Coiffard Aira Contreras Todd W. Costantini Sophie de Brouwer Michelle A. Detry Abhijit Duggal Vladimír Džavík Mark B. Effron Heather Eng Jorge Escobedo Lise J Estcourt Brendan M. Everett Dean Fergusson Mark Fitzgerald Robert Fowler Joshua D. Froess Zhuxuan Fu J.‐P. Galanaud Benjamin Galen Sheetal Gandotra Timothy D. Girard Andrew L. Goodman Herman Goossens Cameron Green Yonatan Greenstein Peter L. Gross Rashan Haniffa Sheila M. Hegde Carolyn M. Hendrickson Alisa M. Higgins Alexander Hindenburg Aluko A. Hope James M Horowitz Christopher M. Horvat David T. Huang Kristin Hudock Beverley J. Hunt Mansoor Husain Robert C. Hyzy Jeffrey R. Jacobson Devachandran Jayakumar Norma Keller Akram Khan Yuri Kim Andrei Kindzelski Andrew J. King M. Margaret Knudson Aaron E. Kornblith Matthew Kutcher Michael Laffan François Lamontagne Grégoire Le Gal

Thrombosis and inflammation may contribute to morbidity mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill Covid-19.

10.1056/nejmoa2103417 article EN New England Journal of Medicine 2021-08-04

<h3>Importance</h3> Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. <h3>Objective</h3> To determine whether hydrocortisone improves outcome patients with COVID-19. <h3>Design, Setting, and Participants</h3> An ongoing adaptive platform trial testing multiple interventions within therapeutic domains, example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 June 17, 2020, 614 adult suspected confirmed COVID-19 were enrolled...

10.1001/jama.2020.17022 article EN cc-by JAMA 2020-09-02

Over 20 years, from October 1989, the Darwin prospective melioidosis study has documented 540 cases tropical Australia, providing new insights into epidemiology and clinical spectrum.The principal presentation was pneumonia in 278 (51%), genitourinary infection 76 (14%), skin 68 (13%), bacteremia without evident focus 59 (11%), septic arthritis/osteomyelitis (4%) neurological 14 (3%). 298 (55%) were bacteremic 116 (21%) developed shock (58 fatal). Internal organ abscesses secondary foci...

10.1371/journal.pntd.0000900 article EN cc-by PLoS neglected tropical diseases 2010-11-30

Background: Complications of Staphylococcus aureus bacteremia (SAB) are often difficult to identify.The ability accurately predict the likelihood these complications would impact patient management.This investigation sought define readily available clinical characteristics that could help identify patients at risk for complicated SAB.Methods: A prospective, observational cohort study was conducted from September 1994 through December 1999.Patients were followed up 12 weeks after initial...

10.1001/archinte.163.17.2066 article EN Archives of Internal Medicine 2003-09-22
Ann Versporten Peter Zarb Isabelle Caniaux Marie-Françoise Gros Nico Drapier and 95 more Mark L. Miller Vincent Jarlier Dilip Nathwani Herman Goossens Andi Koraqi Iris Hoxha Silva Tafaj Denada Lacej Martín Hojman Rodolfo Quirós Lilit Ghazaryan Kelly A. Cairns Allen C. Cheng Kylie Horne Fiona Doukas Thomas Gottlieb Jameela Alsalman Koen Magerman Gounongbe YT Marielle Amela Dedeić-Ljubović André Afonso Machado Coelho Ana Cristina Gales Emma Keuleyan Deana Sabuda Jennifer Boswell John Conly Álvaro Rojas Camila Carvajal Jaime Labarca Antonio L. Solano Carlos Ramírez Valverde Juan Villalobos-Vindas Irina Pristaš Vanda Plečko Niki I. Paphitou Erjona Shaqiri Maija-Liisa Rummukainen Karaman Pagava Irma Korinteli Tobias Brandt Sabine Messler Anthony Enimil Εlias Iosifidis Emmanuel Roilides Mamadou Saliou Sow Sharmila Sengupta Joby V. George Aruna Poojary Priyanka Patil Jafar Soltani Zahra Jafarpour Hadi Ameen David Fitzgerald ‪Yasmin Maor‬‏ Michal Chowers Elizabeth Temkin Susanna Esposito Luca Arnoldo Silvio Brusaferro Yoshiaki Gu Feras Darwish Elhajji Nam Joong Kim Baktygul Kambaralieva Jana Pavāre Lelde Zarakauska Vytautas Usonis Sigita Burokienė Inga Ivaškevičienė Gordana Mijović Nataša Duborija-Kovačević Kristen Bondesio Kenneth Iregbu O.O. Oduyebo Denis Raka Lul Raka Svetlana Rachina Mushira Enani Mohamed Al Shehri Biljana Carević Gorana Dragovac Dušanka Obradović Aleksandra Stojadinović Lili Radulovic Jia En Wu Gladys Wei Teng Chung Hui Hiong Chen Paul Anantharajah Tambyah David Chien Lye Sock Hoon Tan Tat Ming Ng Hui Lin Tay Moi Lin Ling Maciej Piotr Chlebicki Andrea Lay‐Hoon Kwa Winnie Lee

BackgroundThe Global Point Prevalence Survey (Global-PPS) established an international network of hospitals to measure antimicrobial prescribing and resistance worldwide. We aimed assess in hospital inpatients.MethodsWe used a standardised surveillance method collect detailed data about from worldwide, which were grouped by UN region. The internet-based survey included all inpatients (adults, children, neonates) receiving who on the ward at 0800 h one specific day between January September,...

10.1016/s2214-109x(18)30186-4 article EN cc-by-nc-nd The Lancet Global Health 2018-04-23
Patrick R. Lawler Ewan C. Goligher Jeffrey S. Berger Matthew D. Neal Bryan J. McVerry and 95 more José Carlos Nicolau Michelle N. Gong Marc Carrier Robert S Rosenson Harmony R. Reynolds Alexis F. Turgeon Jorge Escobedo David T. Huang Charlotte Bradbury Brett L. Houston Lucy Z. Kornblith Anand Kumar Susan R. Kahn Mary Cushman Zoe McQuilten Arthur S. Slutsky Keri S. Kim Anthony Gordon Bridget‐Anne Kirwan Maria M. Brooks Alisa M. Higgins Roger Lewis Elizabeth Lorenzi Scott Berry Lindsay R. Berry Aaron W. Aday Farah Al-Beidh Djillali Annane Yaseen M. Arabi Diptesh Aryal Lisa Baumann Kreuziger Abi Beane Zahra Bhimani Shailesh Bihari Henny H. Billett Lindsay Bond Marc J. M. Bonten Frank Brunkhorst Meredith Buxton Adrian Buzgau Lana A. Castellucci Sweta Chekuri Jen‐Ting Chen Allen C. Cheng Tamta Chkhikvadze Benjamin Coiffard Todd W. Costantini Sophie de Brouwer Lennie Derde Michelle A. Detry Abhijit Duggal Vladimír Džavík Mark B. Effron Lise J Estcourt Brendan M. Everett Dean Fergusson Mark Fitzgerald Robert Fowler J.‐P. Galanaud Benjamin Galen Sheetal Gandotra Sebastián García‐Madrona Timothy D. Girard Lucas C. Godoy Andrew L. Goodman Herman Goossens Cameron Green Yonatan Greenstein Peter L Gross Naomi M. Hamburg Rashan Haniffa George P. Hanna Nicholas Hanna Sheila M. Hegde Carolyn M. Hendrickson R. Duncan Hite Alexander Hindenburg Aluko A. Hope James M Horowitz Christopher M. Horvat Kristin Hudock Beverley J. Hunt Mansoor Husain Robert C. Hyzy Vivek N. Iyer Jeffrey R. Jacobson Devachandran Jayakumar Norma Keller Akram Khan Yuri Kim Andrei Kindzelski Andrew J. King M. Margaret Knudson Aaron E. Kornblith Vidya Krishnan

Thrombosis and inflammation may contribute to the risk of death complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation improve outcomes in noncritically ill who are hospitalized Covid-19.In this open-label, adaptive, multiplatform, controlled trial, we randomly assigned were Covid-19 not critically (which was defined as an absence critical care-level organ support at enrollment) receive pragmatically regimens either...

10.1056/nejmoa2105911 article EN New England Journal of Medicine 2021-08-04

These guidelines are intended for use by healthcare professionals who care children and adults with suspected or confirmed infectious diarrhea. They not to replace physician judgement regarding specific patients clinical public health situations. This document does provide detailed recommendations on infection prevention control aspects related

10.1093/cid/cix669 article EN Clinical Infectious Diseases 2017-07-26

Abstract These guidelines are intended for use by healthcare professionals who care children and adults with suspected or confirmed infectious diarrhea. They not to replace physician judgement regarding specific patients clinical public health situations. This document does provide detailed recommendations on infection prevention control aspects related

10.1093/cid/cix959 article EN Clinical Infectious Diseases 2017-11-29

There is broad interest in improved methods to generate robust evidence regarding best practice, especially settings where patient conditions are heterogenous and require multiple concomitant therapies. Here, we present the rationale design of a large, international trial that combines features adaptive platform trials with pragmatic point-of-care determine treatment strategies for patients admitted an intensive care unit severe community-acquired pneumonia. The uses novel design, entitled...

10.1513/annalsats.202003-192sd article EN cc-by-nc-nd Annals of the American Thoracic Society 2020-04-08

While Southeast Asia and northern Australia are well recognized as the major endemic regions for melioidosis, recent reports have expanded zone. Severe weather events environmental disasters such 2004 Asian tsunami unmasked locations of sporadic cases reconfirmed endemicity in Indonesia. The region now includes majority Indian subcontinent, southern China, Hong Kong Taiwan. Sporadic occurred Brazil elsewhere Americas island communities New Caledonia, Pacific Ocean, Mauritius Ocean. Some...

10.1016/s0035-9203(08)70002-6 article EN Transactions of the Royal Society of Tropical Medicine and Hygiene 2008-12-01

Abstract SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China late and has since then caused a global pandemic. While molecular assays to directly detect the viral genetic material are available for diagnosis of infection, we currently lack serological suitable specifically SARS-CoV-2 antibodies. Here describe enzyme-linked immunosorbent (ELISA) that developed using recombinant antigens derived from spike...

10.1101/2020.03.17.20037713 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2020-03-18

Abstract Introduction Mortality of patients on extracorporeal membrane oxygenation (ECMO) remains high. The objectives this study were to assess the factors associated with outcome undergoing ECMO in a large referral centre and compare veno-arterial (VA ECMO) veno-venous (VV ECMO). Methods We reviewed prospectively obtained database patients' medical records between January 2005 June 2011. Demographic characteristics, illness severity at admission, indication, organ failure scores before...

10.1186/cc12681 article EN cc-by Critical Care 2013-04-18

The coronavirus disease pandemic was declared in March 2020, as the southern hemisphere’s winter approached. Australia expected co-circulation of severe acute respiratory syndrome 2, influenza and other seasonal viruses. However, notifications were 7,029 (March–September) compared with an average 149,832 for same period 2015–2019*, despite substantial testing. Restrictions on movement within into may have temporarily eliminated influenza. Other pathogens also showed remarkably changed activity 2020.

10.2807/1560-7917.es.2020.25.47.2001847 article EN cc-by Eurosurveillance 2020-11-26

Prosthetic joint infections remain a major complication of arthroplasty. At present, local and international guidelines recommend cefazolin as surgical antibiotic prophylaxis at the time This retrospective cohort study conducted across 10 hospitals over 3-year period (January 2006 to December 2008) investigated epidemiology microbiological etiology prosthetic infections. There were 163 cases infection identified. From review culture results, methicillin-resistant Staphylococcus aureus (MRSA)...

10.1128/aac.06246-11 article EN Antimicrobial Agents and Chemotherapy 2012-02-07

Fluoroquinolone antimicrobial drugs are highly bioavailable, broad-spectrum agents with activity against gram-negative pathogens, especially those resistant to other classes of drugs. Australia has restricted the use quinolones in humans through its national pharmaceutical subsidy scheme; and, regulation, not permitted food-producing animals. As a consequence, resistance fluoroquinolones community been slow emerge and remained at low levels key such as Escherichia coli. In contrast policies...

10.3201/eid1809.111515 article EN cc-by Emerging infectious diseases 2012-08-17

<h3>Importance</h3> Methicillin-resistant<i>Staphylococcus aureus</i>(MRSA) bacteremia is associated with mortality of more than 20%. Combining standard therapy a β-lactam antibiotic has been reduced mortality, although adequately powered randomized clinical trials this intervention have not conducted. <h3>Objective</h3> To determine whether combining an antistaphylococcal effective alone in patients MRSA bacteremia. <h3>Design, Setting, and Participants</h3> Open-label, trial conducted at...

10.1001/jama.2020.0103 article EN JAMA 2020-02-11

Significance As the recall of CD8 + T cell memory promotes rapid recovery in, for example, influenza, we investigated circulating SARS-CoV-2−specific cells from COVID-19 patients. For two HLA-A*02:01 epitopes, found that, while ex vivo frequencies responding were approximately fivefold higher than pre−COVID-19 samples, they ∼10-fold lower influenza or EBV-specific cells. Additionally, recovered convalescent patients had an atypically high prevalence stem memory, central and naïve phenotypes....

10.1073/pnas.2015486117 article EN cc-by Proceedings of the National Academy of Sciences 2020-09-10

Background: The Kingdom of Saudi Arabia has experienced a prolonged outbreak Middle East Respiratory Syndrome (MERS) coronavirus since 2012. Healthcare workers (HCWs) form significant risk group for infection. Objectives: aim this survey was to assess the knowledge, attitudes, infection control practices and educational needs HCWs in MERS other emerging infectious diseases. Methods: 1500 from Ministry Health were invited fill questionnaire developed cover objectives 9 September 2015 8...

10.3390/ijerph13121214 article EN International Journal of Environmental Research and Public Health 2016-12-06
Coming Soon ...